GlassScriptPhysician profile
Scott Gm King
NPI 1720082761
$20,133.93
in general payments reported to CMS, 2019-2025
10 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $16.27 · 2021: $21.78 · 2022: $2,700 · 2023: $186 · 2024: $1,473 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $15K · Travel and Lodging: $1,447 · Food and Beverage: $261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $15,486.97 |
| Travel and Lodging | $1,446.93 |
| Food and Beverage | $261.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nextstep Arthropedix, LLC | $18,306.45 | 2019-2025 | Insitu Hip System |
| Novus Surgical Consultants | $1,446.93 | 2024 | |
| Stryker Corporation | $149.39 | 2019-2023 | Mako |
| Zimmer Biomet Holdings, INC. | $80.16 | 2019 | |
| Coloplast Corp | $49.66 | 2025 | |
| Maxx Orthopedics, INC. | $42.14 | 2023 | |
| Smith+Nephew, INC. | $21.78 | 2021 | |
| Merck Sharp & Dohme LLC | $17.23 | 2024 | Bridion |
| Horizon Therapeutics Plc | $11.69 | 2020 | |
| Heraeus Medical, LLC. | $8.50 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.